JP2021514624A5 - - Google Patents
Info
- Publication number
- JP2021514624A5 JP2021514624A5 JP2020544261A JP2020544261A JP2021514624A5 JP 2021514624 A5 JP2021514624 A5 JP 2021514624A5 JP 2020544261 A JP2020544261 A JP 2020544261A JP 2020544261 A JP2020544261 A JP 2020544261A JP 2021514624 A5 JP2021514624 A5 JP 2021514624A5
- Authority
- JP
- Japan
- Prior art keywords
- tmprss2
- expression levels
- cutoff value
- probability score
- predetermined cutoff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025061707A JP2025096376A (ja) | 2018-02-22 | 2025-04-03 | 前立腺癌の検出および治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862633675P | 2018-02-22 | 2018-02-22 | |
| US62/633,675 | 2018-02-22 | ||
| PCT/US2019/018878 WO2019165021A1 (en) | 2018-02-22 | 2019-02-21 | Methods for prostate cancer detection and treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061707A Division JP2025096376A (ja) | 2018-02-22 | 2025-04-03 | 前立腺癌の検出および治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021514624A JP2021514624A (ja) | 2021-06-17 |
| JP2021514624A5 true JP2021514624A5 (enExample) | 2022-02-28 |
| JP7662337B2 JP7662337B2 (ja) | 2025-04-15 |
Family
ID=65686083
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544261A Active JP7662337B2 (ja) | 2018-02-22 | 2019-02-21 | 前立腺癌の検出および治療方法 |
| JP2025061707A Pending JP2025096376A (ja) | 2018-02-22 | 2025-04-03 | 前立腺癌の検出および治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025061707A Pending JP2025096376A (ja) | 2018-02-22 | 2025-04-03 | 前立腺癌の検出および治療方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US11410748B2 (enExample) |
| EP (2) | EP4538393A3 (enExample) |
| JP (2) | JP7662337B2 (enExample) |
| KR (2) | KR20260018206A (enExample) |
| CN (2) | CN112673115B (enExample) |
| AU (2) | AU2019224025B2 (enExample) |
| BR (1) | BR112020016989A2 (enExample) |
| CA (1) | CA3091647A1 (enExample) |
| DK (1) | DK3755816T3 (enExample) |
| ES (1) | ES3023842T3 (enExample) |
| IL (1) | IL276748A (enExample) |
| MX (2) | MX2020008702A (enExample) |
| PL (1) | PL3755816T3 (enExample) |
| SG (1) | SG11202007922XA (enExample) |
| WO (1) | WO2019165021A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4041886A1 (en) | 2019-10-10 | 2022-08-17 | Liquid Biopsy Research LLC | Compositions, methods and kits for biological sample and rna stabilization |
| US20230049979A1 (en) * | 2020-02-06 | 2023-02-16 | OncoHost Ltd. | Machine learning prediction of therapy response |
| IL310769A (en) | 2021-08-11 | 2024-04-01 | Oncohost Ltd | Predicting patient response |
| US20230326554A1 (en) * | 2022-04-08 | 2023-10-12 | Rutgers, The State University Of New Jersey | Identifying treatment response signatures |
| WO2024081796A1 (en) | 2022-10-12 | 2024-04-18 | Liquid Biopsy Research LLC | Methods for prostate cancer detection in saliva |
| GB2623570B (en) * | 2022-10-21 | 2025-07-23 | Wobble Genomics Ltd | Method and products for biomarker identification |
| KR102891032B1 (ko) * | 2022-12-29 | 2025-12-03 | 재단법인대구경북과학기술원 | 혈액 단구세포 전사체 생체표지자를 이용한 전이성 전립선암 진단용 바이오마커 및 이의 용도 |
| CN116908444B (zh) * | 2023-09-13 | 2023-12-19 | 中国医学科学院北京协和医院 | 血浆max自身抗体在晚期非小细胞肺癌pd-1单抗联合化疗治疗预后预测中的应用 |
| CN119964650B (zh) * | 2024-12-24 | 2025-09-30 | 深圳大学 | 一种基于集成学习的基因调控网络推断方法和系统 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2656140A1 (en) * | 2006-07-03 | 2008-01-10 | Exonhit Therapeutics Sa | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| US20100303795A1 (en) * | 2009-05-27 | 2010-12-02 | Soerensen Karina Dalsgaard | Marker of prostate cancer |
| CA3081061C (en) * | 2010-07-27 | 2023-01-03 | Genomic Health, Inc. | Method for using expression of klk2 to determine prognosis of prostate cancer |
| MX351626B (es) | 2012-01-31 | 2017-10-23 | Genomic Health Inc | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. |
| WO2014012176A1 (en) * | 2012-07-20 | 2014-01-23 | Diagnocure Inc. | Methods, kits and compositions for providing a clinical assessment of prostate cancer |
| EP2882869A4 (en) * | 2012-08-07 | 2016-04-20 | Jackson H M Found Military Med | PROSTATE CANCER GENE EXPRESSION PROFILE |
| MY182773A (en) * | 2012-11-20 | 2021-02-05 | Phadia Ab | Method for indicating a presence or non-presence of aggressive prostate cancer |
| EP2945628B1 (en) * | 2013-01-15 | 2020-04-15 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer |
| CN105209636A (zh) * | 2013-03-15 | 2015-12-30 | 麦塔马克基因股份有限公司 | 用于癌症预后的组合物和方法 |
| CN105658810B (zh) * | 2013-06-13 | 2020-08-21 | 南澳大学 | 用于检测前列腺癌的方法 |
| CA2920429C (en) | 2013-08-06 | 2021-11-16 | Exosome Diagnostics, Inc. | Urine biomarker cohorts, gene expression signatures, and methods of use thereof |
| EP3214444A1 (en) | 2016-03-04 | 2017-09-06 | AIT Austrian Institute of Technology GmbH | Prostate cancer diagnostic method and means |
-
2019
- 2019-02-21 US US16/281,315 patent/US11410748B2/en active Active
- 2019-02-21 JP JP2020544261A patent/JP7662337B2/ja active Active
- 2019-02-21 CN CN201980027332.XA patent/CN112673115B/zh active Active
- 2019-02-21 EP EP25156901.8A patent/EP4538393A3/en active Pending
- 2019-02-21 PL PL19709298.4T patent/PL3755816T3/pl unknown
- 2019-02-21 KR KR1020267002939A patent/KR20260018206A/ko active Pending
- 2019-02-21 DK DK19709298.4T patent/DK3755816T3/da active
- 2019-02-21 BR BR112020016989-7A patent/BR112020016989A2/pt unknown
- 2019-02-21 SG SG11202007922XA patent/SG11202007922XA/en unknown
- 2019-02-21 CN CN202510096498.4A patent/CN119932188A/zh active Pending
- 2019-02-21 CA CA3091647A patent/CA3091647A1/en active Pending
- 2019-02-21 WO PCT/US2019/018878 patent/WO2019165021A1/en not_active Ceased
- 2019-02-21 KR KR1020207026864A patent/KR102921718B1/ko active Active
- 2019-02-21 ES ES19709298T patent/ES3023842T3/es active Active
- 2019-02-21 EP EP19709298.4A patent/EP3755816B1/en active Active
- 2019-02-21 MX MX2020008702A patent/MX2020008702A/es unknown
- 2019-02-21 AU AU2019224025A patent/AU2019224025B2/en active Active
-
2020
- 2020-08-17 IL IL276748A patent/IL276748A/en unknown
- 2020-08-20 MX MX2025000449A patent/MX2025000449A/es unknown
-
2022
- 2022-07-26 US US17/815,102 patent/US20230298695A1/en not_active Abandoned
-
2025
- 2025-04-03 JP JP2025061707A patent/JP2025096376A/ja active Pending
- 2025-04-18 US US19/182,880 patent/US20260066046A1/en active Pending
- 2025-09-26 AU AU2025238057A patent/AU2025238057A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220396842A1 (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| Todeschini et al. | Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts | |
| CN110546263B (zh) | 用于检测卵巢肿瘤的试剂盒、装置和方法 | |
| CN119220676A (zh) | 前列腺癌的检测试剂盒或装置以及检测方法 | |
| CA2623425A1 (en) | Methods for diagnosing pancreatic cancer | |
| JP2025510477A (ja) | メチル化バリアントを使用した腫瘍画分推定 | |
| CN106414774A (zh) | 胆道癌的检测试剂盒或装置以及检测方法 | |
| US20180142303A1 (en) | Methods and compositions for diagnosing or detecting lung cancers | |
| WO2016097120A1 (en) | Method for the prognosis of hepatocellular carcinoma | |
| Shah et al. | Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer | |
| US20230257826A1 (en) | Methods for predicting prostate cancer and uses thereof | |
| RS59161B1 (sr) | Mikro-rnk biomarkeri za identifikovanje rizika i/ili dijagnostikovanje tumora pluća | |
| Kang et al. | A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone | |
| Mengual et al. | Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers | |
| US11732305B2 (en) | Method and kit for diagnosing early stage pancreatic cancer | |
| EP4244393A1 (en) | Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer | |
| JP2020528274A5 (enExample) | ||
| CN115992229B (zh) | 一种胰腺癌预后风险评估的lncRNA标记物、模型及其应用 | |
| WO2019175786A1 (en) | An in vitro diagnostic method for prostate cancer and related kit | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| US20240093306A1 (en) | Micro rna liver cancer markers and uses thereof | |
| JP2024035040A (ja) | 分析方法、キット及び検出用デバイス | |
| WO2025105011A1 (en) | Method for determining pancreatic cancer | |
| Axelsson et al. | PD46-05 GENETIC ABERRATIONS IDENTIFIED IN FOCAL BARBOTAGES–a COMPLEMENTARY DIAGNOSTIC TOOL IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC) | |
| CN119685479A (zh) | 用于胰腺癌早期诊断的sEV mRNA组合标志物、其应用及检测试剂盒 |